Next Article in Journal / Special Issue
Differential Contributions of the Complement Anaphylotoxin Receptors C5aR1 and C5aR2 to the Early Innate Immune Response against Staphylococcus aureus Infection
Previous Article in Journal
Studies of Immune Responses in Candida vaginitis
Previous Article in Special Issue
Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo Exposures
Article Menu

Export Article

Open AccessBrief Report
Pathogens 2015, 4(4), 708-721; doi:10.3390/pathogens4040708

Kinase Inhibitors that Increase the Sensitivity of Methicillin Resistant Staphylococcus aureus to β-Lactam Antibiotics

1,2,3,†
,
1,†,‡
,
1,2,3,†,§
,
2
,
2
and
1,2,3,*
1
Department of Pediatric Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98195, USA
2
Seattle Children’s Research Institute, 1900 Ninth Avenue, Seattle, WA 98101, USA
3
Department of Global Health, University of Washington School of Public Health, Seattle, WA 98195, USA
These authors contributed equally to this work.
Current address: LabCorp Clinical Trials, Seattle, WA 98109, USA.
§
Current address: Pacific Northwest National Laboratory, Richland, WA 99354, USA.
*
Author to whom correspondence should be addressed.
Academic Editor: Rachel McLoughlin
Received: 24 August 2015 / Revised: 16 October 2015 / Accepted: 20 October 2015 / Published: 22 October 2015
(This article belongs to the Special Issue Staphylococcus Aureus Infection)
View Full-Text   |   Download PDF [1270 KB, uploaded 22 October 2015]   |  

Abstract

Staphylococcus aureus are Gram-positive bacteria that are the leading cause of recurrent infections in humans that include pneumonia, bacteremia, osteomyelitis, arthritis, endocarditis, and toxic shock syndrome. The emergence of methicillin resistant S. aureus strains (MRSA) has imposed a significant concern in sustained measures of treatment against these infections. Recently, MRSA strains deficient in expression of a serine/threonine kinase (Stk1 or PknB) were described to exhibit increased sensitivity to β-lactam antibiotics. In this study, we screened a library consisting of 280 drug-like, low-molecular-weight compounds with the ability to inhibit protein kinases for those that increased the sensitivity of wild-type MRSA to β-lactams and then evaluated their toxicity in mice. We report the identification of four kinase inhibitors, the sulfonamides ST085384, ST085404, ST085405, and ST085399 that increased sensitivity of WT MRSA to sub-lethal concentrations of β-lactams. Furthermore, these inhibitors lacked alerting structures commonly associated with toxic effects, and toxicity was not observed with ST085384 or ST085405 in vivo in a murine model. These results suggest that kinase inhibitors may be useful in therapeutic strategies against MRSA infections. View Full-Text
Keywords: serine/threonine kinase; sulfonamides; antibiotics; inhibition; mouse serine/threonine kinase; sulfonamides; antibiotics; inhibition; mouse
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Vornhagen, J.; Burnside, K.; Whidbey, C.; Berry, J.; Qin, X.; Rajagopal, L. Kinase Inhibitors that Increase the Sensitivity of Methicillin Resistant Staphylococcus aureus to β-Lactam Antibiotics. Pathogens 2015, 4, 708-721.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top